gp 1-515 has been researched along with theobromine in 1 studies
Studies (gp 1-515) | Trials (gp 1-515) | Recent Studies (post-2010) (gp 1-515) | Studies (theobromine) | Trials (theobromine) | Recent Studies (post-2010) (theobromine) |
---|---|---|---|---|---|
8 | 0 | 0 | 1,864 | 174 | 274 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cronstein, BN; Firestein, G; Naime, D | 1 |
1 other study(ies) available for gp 1-515 and theobromine
Article | Year |
---|---|
The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine.
Topics: Adenosine; Adenosine Deaminase; Adenosine Kinase; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Female; Leukocytes; Mice; Mice, Inbred BALB C; Purinergic P1 Receptor Antagonists; Ribonucleosides; Theobromine; Tumor Necrosis Factor-alpha; Xanthines | 1995 |